BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1705659)

  • 21. Metabolic, desmutagenic and anticarcinogenic effects of N-acetylcysteine.
    De Flora S; Rossi GA; De Flora A
    Respiration; 1986; 50 Suppl 1():43-9. PubMed ID: 3809742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
    Milling DM; Maddock MB
    Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a microsomal fraction from rat small intestine for metabolic activation of some promutagens.
    Walters JM; Combes RD
    Carcinogenesis; 1985 Oct; 6(10):1415-20. PubMed ID: 4042271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B.
    De Flora S; Bennicelli C; D'Agostini F; Izzotti A; Camoirano A
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):69-74. PubMed ID: 7534225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic monooxygenase induction and promutagen activation in channel catfish from a contaminated river basin.
    Winston GW; Shane BS; Henry CB
    Ecotoxicol Environ Saf; 1988 Dec; 16(3):258-71. PubMed ID: 3147889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic activation and deactivation of mutagens by preparations of human lung parenchyma and bronchial tree.
    De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Petruzzelli S; Giuntini C
    Mutat Res; 1984 Jan; 139(1):9-14. PubMed ID: 6361547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of DT diaphorase on the mutagenicity of organic and inorganic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Hochstein P
    Carcinogenesis; 1988 Apr; 9(4):611-7. PubMed ID: 2451576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The food pyrolysis product IQ enhances its own activation.
    Ayrton AD; Williams EJ; Rodrigues AD; Ioannides C; Walker R
    Mutagenesis; 1989 May; 4(3):205-7. PubMed ID: 2659938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of short-term mutagenicity test systems in vitro: metabolic activation of indirectly acting mutagens by three immortal rat hepatocyte lines.
    Kulka U; Paul D; Bauchinger M
    Mutagenesis; 1993 May; 8(3):193-7. PubMed ID: 8332081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
    Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked antimutagenic potential of aqueous green tea extracts: mechanism of action.
    Bu-Abbas A; Clifford MN; Walker R; Ioannides C
    Mutagenesis; 1994 Jul; 9(4):325-31. PubMed ID: 7968574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of glutathione conjugation and microsomal oxidation on the mutagenicity of dichloromethane in S. typhimurium.
    Jongen WM; Harmsen EG; Alink GM; Koeman JH
    Mutat Res; 1982 Aug; 95(2-3):183-9. PubMed ID: 6811886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
    Ross MK; Pegram RA
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN; Ioannides C
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues.
    Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S
    Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
    Robertson IG; Zeiger E; Goldstein JA
    Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The process of promutagen biotransformation studied by the Ames test. II. The extent of the manifestation of the mutagenic action of nitrosomorpholine, diethylnitrosamine and cyclophosphane using various subfractions of rat liver homogenate].
    Loknitskaia NN; Fonshteĭn LM
    Genetika; 1985 Dec; 21(12):1932-6. PubMed ID: 4085789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic characterization of the polynuclear aromatic hydrocarbons activating rat-liver preparations used in the mutagenicity test of Ames.
    Tauc M; Hermann M; Dansette PM; Vandecasteele JP
    Mutat Res; 1984 Feb; 125(2):123-33. PubMed ID: 6366528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.